Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human ARHGDIB Protein, N-His

Catalog #:   YHE92402 Specific References (95) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P52566
Protein length: Asn66-Glu201
Overview

Catalog No.

YHE92402

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Asn66-Glu201

Predicted molecular weight

17.92 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P52566

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

ARHGDIB, Rho-GDI beta, Rho GDP-dissociation inhibitor 2, RAP1GN1, Rho GDI 2, GDIA2, GDID4, Ly-GDI

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human ARHGDIB protein
References

KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1. PMID: 34006303

Podocytes and autophagy: a potential therapeutic target in lupus nephritis. PMID: 30755075

Identification of proteomic signatures associated with lung cancer and COPD. PMID: 23665002

Systematic investigation of biomarker-like role of ARHGDIB in breast cancer. PMID: 32176626

Antibodies Against ARHGDIB and ARHGDIB Gene Expression Associate With Kidney Allograft Outcome. PMID: 31651716

Antibodies against ARHGDIB are associated with long-term kidney graft loss. PMID: 31194283

The hematopoietic cell-specific Rho GTPase inhibitor ARHGDIB/D4GDI limits HIV type 1 replication. PMID: 21936715

ATG7 Promotes Bladder Cancer Invasion via Autophagy-Mediated Increased ARHGDIB mRNA Stability. PMID: 31016112

Comprehensive analysis of miRNA-mRNA regulatory network and potential drugs in chronic chagasic cardiomyopathy across human and mouse. PMID: 34844599

ARHGDIB and AT1R autoantibodies are differentially related to the development and presence of chronic antibody-mediated rejection and fibrosis in kidney allografts. PMID: 33358038

Screening anlotinib responders via blood-based proteomics in non-small cell lung cancer. PMID: 35867072

PD-L1 enhances migration and invasion of trophoblasts by upregulating ARHGDIB via transcription factor PU.1. PMID: 36138021

The Dual Function of RhoGDI2 in Immunity and Cancer. PMID: 36835422

Inflammatory and immune-related factor Caspase 1 contributes to the development of oral lichen planus. PMID: 34481194

Placenta-specific novel splice variants of Rho GDP dissociation inhibitor β are highly expressed in cancerous cells. PMID: 23206989

Adenosine Inhibits Ovarian Cancer Growth Through Regulating RhoGDI2 Protein Expression. PMID: 32109988

GM3 signals regulating TNF-alpha expression are mediated by Rictor and Arhgdib in mouse melanoma B16 cells. PMID: 18523362

Pathways of metastasis suppression in bladder cancer. PMID: 20013033

RhoGDI2 as a therapeutic target in cancer. PMID: 20001211

Increased dermal collagen bundle alignment in systemic sclerosis is associated with a cell migration signature and role of Arhgdib in directed fibroblast migration on aligned ECMs. PMID: 28662216

Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma. PMID: 17897297

SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies. PMID: 35835296

Therapeutic effects of Euphorbia Pekinensis and Glycyrrhiza glabra on Hepatocellular Carcinoma Ascites Partially Via Regulating the Frk-Arhgdib-Inpp5d-Avpr2-Aqp4 Signal Axis. PMID: 28165501

Unconventional myosin VIIA promotes melanoma progression. PMID: 29361540

Characterizing isomiR variants within the microRNA-34/449 family. PMID: 28192603

LyGDI, a novel SHIP-interacting protein, is a negative regulator of FcγR-mediated phagocytosis. PMID: 21695085

Proteomic characterization of early lung response to breast cancer metastasis in mice. PMID: 30763573

An adventitious interaction of filamin A with RhoGDI2(Tyr153Glu). PMID: 26707877

RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation. PMID: 17826660

Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. PMID: 10433515

TAT-RhoGDI2, a novel tumor metastasis suppressor fusion protein: expression, purification and functional evaluation. PMID: 25142698

Screening and identification of five serum proteins as novel potential biomarkers for cured pulmonary tuberculosis. PMID: 26499913

RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer. PMID: 25516960

CRIF1 deficiency suppresses endothelial cell migration via upregulation of RhoGDI2. PMID: 34437633

Shotgun proteome analysis of protein cleavage in apoptotic cells. PMID: 15846839

Copper-catalyzed azide-alkyne cycloaddition (click chemistry)-based detection of global pathogen-host AMPylation on self-assembled human protein microarrays. PMID: 25073739

Comparison of Two Strategies to Generate Antigen-Specific Human Monoclonal Antibodies: Which Method to Choose for Which Purpose? PMID: 34017336

Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. PMID: 8356058

Study on the transcriptome for breast muscle of chickens and the function of key gene RAC2 on fibroblasts proliferation. PMID: 33676413

Prognosis biomarker and potential therapeutic target CRIP2 associated with radiosensitivity in NSCLC cells. PMID: 34773852

Rictor regulates cell migration by suppressing RhoGDI2. PMID: 22777355

A methylation-driven gene panel predicts survival in patients with colon cancer. PMID: 34184409

Novel Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Uncovered by Data-Independent Acquisition Mass Spectrometry. PMID: 35939567

Structure-activity relationships in flexible protein domains: regulation of rho GTPases by RhoGDI and D4 GDI. PMID: 11114252

Overexpression of RhoGDI2 correlates with the progression and prognosis of pancreatic carcinoma. PMID: 25573518

Differential expression patterns of metastasis suppressor proteins in basal cell carcinoma. PMID: 25428551

Association of D4-GDI expression with breast cancer progression. PMID: 22674302

Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors. PMID: 23149915

LyGDI is a promising biomarker for ovarian cancer. PMID: 20375790

PLCγ is required for RhoGDI2-mediated cisplatin resistance in gastric cancer. PMID: 21986528

Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome. PMID: 31262358

Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity. PMID: 26414765

Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma. PMID: 24788627

VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance. PMID: 24585459

Interferon Gamma Inhibits CXCL8-Induced Proliferation and Migration of Pancreatic Cancer BxPC-3 Cell Line via a RhoGDI2/Rac1/NF-κB Signaling Pathway. PMID: 30192158

Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases. PMID: 19276387

RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells. PMID: 24721928

Genome-wide association study identified copy number variants associated with sporadic colorectal cancer risk. PMID: 29079706

Protective Role of Rho Guanosine Diphosphate Dissociation Inhibitor, Ly-GDI, in Pulmonary Alveolitis. PMID: 26469087

Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis. PMID: 20155427

Identification of ubiquitin target proteins using cell-based arrays. PMID: 17894482

PKCα phosphorylation of RhoGDI2 at Ser31 disrupts interactions with Rac1 and decreases GDI activity. PMID: 22469974

Causes of Positive Pretransplant Crossmatches in the Absence of Donor-Specific Anti-Human Leukocyte Antigen Antibodies: A Single-Center Experience. PMID: 33536364

Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function. PMID: 19321744

Regulation of apoptosis by peptides of fibronectin in human monocytes. PMID: 16502259

Cleavage and nuclear translocation of the caspase 3 substrate Rho GDP-dissociation inhibitor, D4-GDI, during apoptosis. PMID: 10381642

Autoantibodies specific to D4GDI modulate Rho GTPase mediated cytoskeleton remodeling and induce autophagy in T lymphocytes. PMID: 25623267

Invasion and metastasis models for studying RhoGDI2 in bladder cancer. PMID: 18374168

D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness. PMID: 16740694

Clinical significance of Rho GDP dissociation inhibitor 2 in colorectal carcinoma. PMID: 21698524

Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis. PMID: 20596634

RhoGDI2 is expressed in human trophoblasts and involved in their migration by inhibiting the activation of RAC1. PMID: 24554735

Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma. PMID: 21861235

Assessment of roles for the Rho-specific guanine nucleotide dissociation inhibitor Ly-GDI in platelet function: a spatial systems approach. PMID: 28148498

Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells. PMID: 18809735

[MALDI-TOF and SELDI-TOF analysis: "tandem" techniques to identify potential biomarker in fibromyalgia]. PMID: 22257917

RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression. PMID: 21752536

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. PMID: 15173088

RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling. PMID: 31362179

RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration. PMID: 22406535

RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer. PMID: 19351766

Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway. PMID: 23349340

TNF-alpha-mediated neutrophil apoptosis involves Ly-GDI, a Rho GTPase regulator. PMID: 10947073

Freeze-thawing single human embryonic stem cells induce e-cadherin and actin filament network disruption via g13 signaling. PMID: 22227712

14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells. PMID: 24185104

GM3 suppresses anchorage-independent growth via Rho GDP dissociation inhibitor beta in melanoma B16 cells. PMID: 21518140

Vav, a GDP/GTP nucleotide exchange factor, interacts with GDIs, proteins that inhibit GDP/GTP dissociation. PMID: 10664460

D4-GDI is cleaved by caspase-3 during daunorubicin-induced apoptosis in HL-60 cells. PMID: 11989976

Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2. PMID: 16103083

D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. PMID: 8626669

Rutinoside at C7 attenuates the apoptosis-inducing activity of flavonoids. PMID: 14505793

Defective Rho GTPase regulation by IL-1 beta-converting enzyme-mediated cleavage of D4 GDP dissociation inhibitor. PMID: 8752894

Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer. PMID: 22364609

LyGDI functions in cancer metastasis by anchoring Rho proteins to the cell membrane. PMID: 15057873

Differential properties of D4/LyGDI versus RhoGDI: phosphorylation and rho GTPase selectivity. PMID: 9490022

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human ARHGDIB Protein, N-His [YHE92402]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only